Brief: Janux Therapeutics Posts Qtrly Loss Per Share $0.33

Janux Therapeutics

18/03/2022 20:05

March 18 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
    * JANUX THERAPEUTICS INC - $375.0 MILLION IN YEAR-END 2021
CASH,
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
    * JANUX THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.33

Source text for Eikon:  ID:nBw45lbF5a 
Further company coverage:  JANX.O 

 ((reuters.briefs@thomsonreuters.com;))